Organigram Holdings Inc. , through its subsidiaries, produces and sells cannabis and cannabis-derived products in Canada.
Organigram Holdings stock last closed at $1.06, up 6% from the previous day, and has decreased 44.21% in one year. It has overperformed other stocks in the Drug Manufacturers - Specialty & Generic industry by 0.12 percentage points. Organigram Holdings stock is currently +24.71% from its 52-week low of $0.85, and -51.15% from its 52-week high of $2.17.
There are currently 126.16M OGI shares outstanding. The market value of OGI is $133.73M. In the last 24 hours, 440,996 OGI shares were traded.
How to Buy Organigram Holdings Stock
Wondering how to invest in Organigram Holdings stock? Here's how.
Decide where to buy Organigram Holdings stock: You need to choose an online brokerage, but don't worry - we've researched dozens of stock brokerages and apps to help you figure out where to buy Organigram Holdings stock.
Create a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
Deposit money your investment account: Choose your method of payment and add your details.
Research Organigram Holdings stock: The Organigram Holdings ticker symbol is OGI. Is Organigram Holdings stock a good investment? Should you buy shares of OGI? How do OGI's underlying business fundamentals look? Do top analysts think Organigram Holdings is a good buy? Why has OGI's stock price moved recently? (Hint: Our stock research website can help you understand if OGI is a good stock to buy).
Place your OGI trade: Decide if you will purchase OGI shares at the current market price or use a limit order to purchase OGI shares at a given price.
Get the latest news on your OGI investment: Create a watchlist to keep track of your investment in Organigram Holdings stock.
Step 1: Decide where to buy Organigram Holdings stock
You will need a brokerage account in order to access the NASDAQ market and buy OGI shares.
A brokerage account enables you to buy and sell a number of investments, such as stocks, bonds, mutual funds, and ETFs.
Our recommended brokerage: eToro
Based on our analysis, eToro is the best brokerage. eToro gives you:
Invest in stocks with 0% commissions: Invest without commissions.
Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
Access to global financial markets: From Technology to Real Estate, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top exchanges.
Social investing: eToro boasts a community with more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of top investors.
Security: eToro is a regulated and licensed brokerage platform.
Buy other assets: Such as ETFs and cryptos.
Get $10 towards your purchase of shares by opening an account with eToro now. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Create a brokerage account
Now that you've selected the right brokerage, you need to fill out some personal details so you can buy OGI stock today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Research Organigram Holdings stock
Once you have chosen the best place to buy Organigram Holdings stock, it's critical to analyze their stock prior to buying, so you truly wrap your head around the risk as well as the opportunity.
Organigram Holdings Metrics
OGI Price
$1.06
1w %
1.92%
1y %
-44.21%
5y %
-82.57%
P/E
-2.7x
P/B
0.59x
P/S
1.16x
PEG
N/A
Revenue
$115.36M
Earnings
-$36.52M
Fore. Rev. Growth
17.24%
Fore. Earn. Growth
N/A
Market Cap
$133.73M
Next Earnings
May 12, 2025
Next Dividend
N/A
Organigram Holdings Due Diligence Checks
WallStreetZen was created to help part-time investors do more accurate fundamental analysis.
You can see all of the due diligence checks on OGI's stock page.
Is OGI stock properly valued?
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge OGI's fair value.
Using relative valuations methods:
OGI may be undervalued based on its P/B ratio of 0.59x, relative to Drug Manufacturers - Specialty & Generic industry P/B ratio of 2.03x
Last year, OGI revenue was $115.36M. Over the last five year, OGI's revenue has gone up by 10.5% per year. This was faster than the Drug Manufacturers - Specialty & Generic industry average of 7.84%.
No, Organigram Holdings doesn't provide an income stream by paying out dividends.
What others are saying about OGI
One of the major reasons eToro is our favorite brokerage is because of its social trading community.
Click below to see what other traders have to say.
Step 5: Place your OGI trade
There are two main order types:
Market order: A market order is an order to buy or sell a security at the best available price. Market orders are generally the best for newer investors.
Limit order: A limit order allows you to buy or sell a security at a specific price (or better). If you want to be sure you're buying or selling at a particular price, place a limit order.
Hit the Open button and your broker will place your order.
If you want more assistance investing in stocks on eToro, watch the helpful video below:
How much does it cost to buy one Organigram Holdings share?
As of Apr 22, 2025, it costs $1.06 to buy one share of Organigram Holdings stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $0.53, you can buy 0.5 shares of OGI.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.